Recent developments in the field of A 2A and A 3 adenosine receptor antagonists

By Baraldi P.G.   Tabrizi M.A.   Bovero A.   Avitabile B.   Preti D.   Fruttarolo F.   Romagnoli R.   Varani K.   Borea P.A.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 4, 2003-04 ,pp. : 367-382

Elsevier

Access to resources Recommend Favorite

Recent Advances on QSAR-Based Profiling of Agonist and Antagonist A3 Adenosine Receptor Ligands

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 9, 2013-05 ,pp. : 1048-1068

Bentham Science Publishers

Access to resources Recommend Favorite

Medicinal Chemistry of Adenosine A3 Receptor Ligands

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 4, 2003-02 ,pp. : 445-462

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Development of Adenosine Receptor Ligands as Antiinflammatory Drugs

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 13, 2006-07 ,pp. : 1375-1399

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of A₁ adenosine receptor ligands: a survey of recent patent literature

By Giorgi Irene   Nieri Paola  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 7, 2008-07 ,pp. : 677-691

Informa Healthcare

Access to resources Recommend Favorite